Arakis and GeneFormatics Collaborate on Performance Enhanced Medicines
Business Review Editor
Abstract
Arakis collaborates with GeneFormatics for joint discovery of Performance Enhanced Medicines (PEMs) by combining GeneFormatics’ structural proteomics capabilities to identify and describe secondary biochemical functional sites and Arakis’ know-how and databases to define and validate protein targets.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.